← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
National Health Laboratory Service
Johannesburg
$103,182,576
Total funding
11
Grants
Funding over time
peak $20.7M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$103,182,576 · 11
By mechanism
U2G$54,669,581 · 3
U01$25,752,846 · 4
U19$15,823,972 · 2
U51$6,127,700 · 1
U60$808,477 · 1
Investigators at National Health Laboratory Service
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTE$12,868,424
U2G · FY2009 · PS
EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTE$12,000,000
U2G · FY2008 · PS
EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTE$11,647,921
U2G · FY2011 · PS
GH15-1575, S. Africa, STRENGTHENING THE DELIVERY AND EXPANDING ACCESS TO QUALITY LABORATORY SERVICES AND ENHANCING HEALTHCARE WORKER AND LABORATORY SAFETY IN THE REPUBLIC OF SOUTH AFRICA UNDER PEPFAR$5,000,000
U2G · FY2016 · GH
IP16-003, Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09$4,770,431
U01 · FY2020 · IP
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09$4,656,240
U01 · FY2019 · IP
EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTE$4,534,233
U2G · FY2010 · PS
GLOBAL DISEASES DETECTION PROGRAM: SOUTH AFRICA$4,122,766
U19 · FY2011 · GH
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09$3,908,000
U01 · FY2016 · IP
GH12-004, S. Africa: GDD Public Health Research$3,812,620
U19 · FY2015 · GH
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09$3,120,562
U01 · FY2017 · IP
IP24-017 - Collaborative research on influenza and other respiratory pathogens in South Africa$3,000,000
U01 · FY2024 · IP
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09$2,190,000
U01 · FY2018 · IP
EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTE$1,856,681
U2G · FY2011 · PS
GH12-004, S. Africa: GDD Public Health Research$1,749,932
U19 · FY2014 · GH
GH15-1575, S. Africa, STRENGTHENING THE DELIVERY AND EXPANDING ACCESS TO QUALITY LABORATORY SERVICES AND ENHANCING HEALTHCARE WORKER AND LABORATORY SAFETY IN THE REPUBLIC OF SOUTH AFRICA UNDER PEPFAR$1,550,000
U2G · FY2016 · GH
IP24-017 - Collaborative research on influenza and other respiratory pathogens in South Africa$1,500,000
U01 · FY2025 · IP
GDD Public Health Research in South Africa$1,418,978
U19 · FY2012 · GH
Sustaining Surveillance Networks and Response to Seasonal$1,400,000
U51 · FY2013 · IP
EXPANSION OF HIV/AIDS, STD AND TB LABORATORY ACTIVITIES AT THE NATIONAL INSTITUTE$1,385,772
U2G · FY2011 · PS